BOSATRIA Trademark

Trademark Overview

On Tuesday, July 13, 2010, a trademark application was filed for BOSATRIA with the United States Patent and Trademark Office. The USPTO has given the BOSATRIA trademark a serial number of 85083127. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 29, 2021. This trademark is owned by Glaxo Group Limited. The BOSATRIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue
bosatria

General Information

Serial Number85083127
Word MarkBOSATRIA
Filing DateTuesday, July 13, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 29, 2021
Registration Number4554046
Registration DateTuesday, June 24, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 8, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 29, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Friday, January 29, 2021CANCELLED SEC. 8 (6-YR)
Monday, June 24, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, June 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 24, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, April 8, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 8, 2014PUBLISHED FOR OPPOSITION
Wednesday, March 19, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 27, 2014CASE RETURNED TO EXAMINATION
Tuesday, February 18, 2014NOTICE OF ALLOWANCE CANCELLED
Friday, February 21, 2014PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Tuesday, February 4, 2014ASSIGNED TO PETITION STAFF
Friday, January 31, 2014TEAS PETITION TO AMEND BASIS RECEIVED
Wednesday, August 14, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 13, 2013EXTENSION 5 GRANTED
Wednesday, August 7, 2013EXTENSION 5 FILED
Wednesday, August 7, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 16, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 15, 2013EXTENSION 4 GRANTED
Monday, January 14, 2013EXTENSION 4 FILED
Monday, January 14, 2013TEAS EXTENSION RECEIVED
Friday, August 10, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 9, 2012EXTENSION 3 GRANTED
Tuesday, July 17, 2012EXTENSION 3 FILED
Tuesday, July 17, 2012TEAS EXTENSION RECEIVED
Wednesday, February 8, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 7, 2012EXTENSION 2 GRANTED
Wednesday, January 11, 2012EXTENSION 2 FILED
Friday, February 3, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 11, 2012TEAS EXTENSION RECEIVED
Wednesday, July 20, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 18, 2011EXTENSION 1 GRANTED
Monday, July 18, 2011EXTENSION 1 FILED
Monday, July 18, 2011TEAS EXTENSION RECEIVED
Tuesday, February 15, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 21, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 21, 2010PUBLISHED FOR OPPOSITION
Friday, November 12, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 12, 2010ASSIGNED TO LIE
Friday, October 29, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 26, 2010ASSIGNED TO EXAMINER
Friday, July 16, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 16, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

bosatria pharmaceutical disorders treatment substances preparations diseases respiratory gastrointestinal neurological hepatological